InvestorsHub Logo
Followers 42
Posts 2027
Boards Moderated 0
Alias Born 02/08/2020

Re: None

Friday, 10/16/2020 7:51:14 PM

Friday, October 16, 2020 7:51:14 PM

Post# of 232963
Off another board, makes a lot of sense.
"Potential regulatory path forward"

This indicates one of the DSMC's recommendations is a pathway forward into market for the drug Leronlimab. This means now.

Continuing the trial is not a pathway forward for their product.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News